NYSE: HNGE Hinge Health, Inc. 10-Q

Hinge Health debuts with 47% revenue growth, 85% margins, and $105M in buybacks

Filed May 7, 2026 · Period ending March 31, 2026 · ~1 min read

Key Changes

  • high

    Revenue surged 47% YoY to $182M in Q1 2026, driven by existing client expansion. Gross margin improved to 85% (up 4 points) through care team and supply chain efficiencies. Net income more than doubled to $35M.

    MD&A: Financial Results verify on EDGAR →
  • high

    Free cash flow jumped from $4M to $42M (23% margin), enabling $105M in share repurchases under a new $250M program. Company maintains $406M in cash and marketable securities.

    MD&A: Cash Flow & Capital Allocation verify on EDGAR →
  • high

    Three health plan partners (HCSC, Elevance, Aetna) represent ~40% of revenue; 84% of total revenue flows through partner relationships. Loss of any major partner would materially impact results.

    Risk Factors: Client Concentration verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (SMID 10-Q) is open in full — no account needed.

Partner

Trade HNGE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.